12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-01), Krystal Biotech's 12-1 Month Momentum % is 111.82%.
The industry rank for Krystal Biotech's 12-1 Month Momentum % or its related term are showing as below:
KRYS's 12-1 Month Momentum % is ranked better than 91.81% of 1478
companies
in the Biotechnology industry
Industry Median: -20.535
vs KRYS: 111.82
Competitive Comparison of Krystal Biotech's 12-1 Month Momentum %
For the Biotechnology subindustry, Krystal Biotech's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krystal Biotech's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Krystal Biotech's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Krystal Biotech's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Krystal Biotech 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Krystal Biotech's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Krystal Biotech (Krystal Biotech) Business Description
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRYS has been successfully added to your